| 8th Jan 2020 7:00 am |
RNS |
China licence agreement for Feraccru/Accrufer |
| 12th Dec 2019 5:30 pm |
RNS |
Eland Oil & Gas |
| 29th Nov 2019 3:31 pm |
RNS |
Holding(s) in Company |
| 25th Nov 2019 7:00 am |
RNS |
QCA Corporate Governance Code |
| 30th Oct 2019 7:30 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): More choice for clinicians and patients |
| 22nd Oct 2019 7:00 am |
RNS |
Positive results presented at UEG Week 2019 |
| 26th Sep 2019 7:00 am |
RNS |
Investor Presentation |
| 2nd Sep 2019 9:14 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): FDA approval ushers in a new era for Shield |
| 29th Aug 2019 7:00 am |
RNS |
Investor presentations |
| 15th Aug 2019 10:17 am |
RNS |
Director/PDMR Shareholding |
| 7th Aug 2019 7:00 am |
RNS |
Half-year Report |
| 5th Aug 2019 11:22 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX) FDA approval opens door to major US opportunity |
| 31st Jul 2019 1:21 pm |
RNS |
Notice of Results |
| 26th Jul 2019 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 26th Jul 2019 2:00 pm |
RNS |
Price Monitoring Extension |
| 26th Jul 2019 7:00 am |
RNS |
FDA approves Feraccru® with a broad label |
| 2nd Jul 2019 12:00 pm |
RNS |
Additional Listing |
| 13th Jun 2019 2:16 pm |
RNS |
Result of AGM |
| 3rd Jun 2019 7:00 am |
RNS |
Update on Legal Proceedings |
| 13th May 2019 12:00 pm |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): All in the execution |
| 8th May 2019 7:00 am |
RNS |
Appointment of Joint Broker |
| 2nd May 2019 7:00 am |
RNS |
Investor presentation |
| 1st May 2019 11:58 am |
RNS |
Additional Listing |
| 30th Apr 2019 7:00 am |
RNS |
2018 Annual Report and 2019 AGM Notice |
| 26th Apr 2019 6:05 pm |
RNS |
PDMR Acquisition of Shares |
| 24th Apr 2019 7:00 am |
RNS |
Major extension to approval in Switzerland |
| 17th Apr 2019 5:06 pm |
RNS |
Grant of share options |
| 17th Apr 2019 5:01 pm |
RNS |
PDMR Acquisition of Shares and Additional Listing |
| 17th Apr 2019 4:56 pm |
RNS |
PDMR Acquisition of Shares |
| 11th Apr 2019 4:40 pm |
RNS |
Holding(s) in Company |
| 8th Apr 2019 3:42 pm |
RNS |
Additional Listing |
| 3rd Apr 2019 7:00 am |
RNS |
Final Results |
| 1st Apr 2019 5:44 pm |
RNS |
Additional Listing |
| 1st Apr 2019 12:00 pm |
RNS |
Change of Adviser |
| 27th Mar 2019 7:00 am |
RNS |
Notice of Results |
| 14th Mar 2019 3:31 pm |
RNS |
Positive decision on Feraccru®'s process patent |
| 4th Mar 2019 7:00 am |
RNS |
Positive results for Feraccru® in AEGIS-H2H study |
| 29th Jan 2019 7:00 am |
RNS |
Positive results of AEGIS-CKD study |
| 28th Jan 2019 7:15 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX): Cast-iron investment |
| 24th Jan 2019 7:00 am |
RNS |
Business and trading update |
